Skip to main content
Clinical Trials/ISRCTN11331226
ISRCTN11331226
Completed
未知

Evaluating the psychobiological effectiveness and user experience of virtual reality heart rate variability biofeedback intervention programme for stress management in healthy individuals: a randomized wait-list control trial

Eidgenössische Technische Hochschule Zürich0 sites99 target enrollmentMay 26, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Reduction of stress and stress-related symptoms in healthy individuals
Sponsor
Eidgenössische Technische Hochschule Zürich
Enrollment
99
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2023 Results article in https://doi.org/10.1186/s44247-023-00042-z (added 14/11/2023)

Registry
who.int
Start Date
May 26, 2023
End Date
October 25, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Fluent in German
  • 2\. Have normal or corrected\-to\-normal vision
  • 3\. Exhibit no disability of arms or hands
  • 4\. Have obtained at least a secondary school diploma
  • 5\. 18\-40 years of age

Exclusion Criteria

  • 1\. Self\-reported acute (including common cold) and chronic somatic diseases (including epilepsy, photo epilepsy or other pre\-existing neurological conditions)
  • 2\. Psychiatric disorders
  • 3\. Regular medication or medication in the last 2 months to treat acute illnesses, or any cardioactive medication (e.g., antidepressant, antipsychotic, antihypertensive),
  • 4\. The consumption of psychoactive substances in the last 3 months
  • 5\. Heavy drinking (equal or greater to 15 and equal or greater to 8 drinks per week for men and women, respectively)
  • 6\. Consumption of tobacco (more than 5 cigarettes/week). If participants report to smoke more than 5 cigarettes/week but only on weekends (e.g., social events, parties) they are not excluded.
  • 7\. Women with irregular menstrual cycles
  • 8\. Woman who use hormonal contraception, are pregnant or lactating

Outcomes

Primary Outcomes

Not specified

Similar Trials